Affimed

YTD

ALL

Why Robinhood?

You can watch Affimed and buy or sell other stocks, ETFs, and their options commission-free!

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.

CEO

Shawn M. Leland, PharmD

CEOShawn M. Leland, PharmD

Employees

—

Employees—

Headquarters

Mannheim, Baden Wuerttemberg

HeadquartersMannheim, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

—

Employees—

AFMD Key Statistics

Market cap

96.88M

Market cap96.88M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

12.17K

Average volume12.17K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.79

52 Week high$1.79

52 Week low

—

52 Week low—

Stock Snapshot

Affimed(AFMD) stock is priced at $5.91, giving the company a market capitalization of 96.88M.

During the trading day, Affimed(AFMD) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for Affimed(AFMD) stock has reached 0, versus its average volume of 12.17K.

People also own

Based on the portfolios of people who own AFMD. This list is generated using Robinhood data, and it’s not a recommendation.